Enhancing Effectiveness of Immune Checkpoint Therapy in Neuroblastoma |
Children’s Hospital Los Angeles / Shahab Asgharzadeh, MD |
Innovation Grants |
2015 |
California |
Identifying Ewing Sarcoma Developmental Vulnerabilities |
Children’s Hospital Los Angeles / Elena Vasileva, PhD |
Young Investigator Grants |
2023 |
California |
Antibody Targeted Natural Killer Cell-Derived Extracellular Vesicles for the Treatment of Childhood Acute Lymphoblastic Leukemia and Neuroblastoma |
Children’s Hospital Los Angeles / Robert Seeger, MD & Alan Wayne, MD |
Innovation Grants |
2015 |
California |
Saving Lives, Saving Neurons, the Head Start Consortium for Young Children with Malignant Central Nervous System Tumors
|
Children’s Hospital Los Angeles / Jonathan Finlay, MD |
Phase I/II Infrastructure Grants |
2007 |
California |
Targeting PI3Kdelta in Childhood Acute Lymphoblastic Leukemia |
Children’s Hospital Los Angeles / Yong-mi Kim, MD & Nora Heisterkamp, PhD |
Reach Grants |
2015 |
California |
Symptom Burden, Health-Related Quality of Life and Health Care Utilization Among Children Undergoing Hematopoietic Stem Cell Transplantation: Impact of Parent Sleep, Fatigue and Psychological Distress |
Children’s Hospital Los Angeles / Jessica Ward, PhD |
Nurse Researcher Fellowship Grant |
2017 |
California |
Circulating Repetitive Element RNAs as an Osteosarcoma Marker |
Children’s Hospital Los Angeles / David Cobrinik, MD/PhD |
Innovation Grants |
2018 |
California |
The role of OCT4 in self-renewal signaling and drug-resistance of childhood acute lymphoblastic leukemia
|
Children’s Hospital Los Angeles / Markus Muschen |
Innovation Grants |
2008 |
California |
Preclinical Studies of Gli1 Inhibition in Ewing Family Tumors
|
Children’s Hospital Los Angeles / William May |
Innovation Grants |
2008 |
California |
New Approaches to Neuroblastoma Therapy
|
Children’s Hospital Los Angeles / Robert Seeger |
Phase I/II Infrastructure Grants |
2008 |
California |